
Amanda L. Aguirre
Examiner (ID: 17942, Phone: (571)272-5592 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626 |
| Total Applications | 850 |
| Issued Applications | 613 |
| Pending Applications | 94 |
| Abandoned Applications | 188 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17713580
[patent_doc_number] => 11377563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Ionic polymers comprising fluorescent or colored reporter groups
[patent_app_type] => utility
[patent_app_number] => 16/307876
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14361
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 450
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307876
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307876 | Ionic polymers comprising fluorescent or colored reporter groups | Jun 5, 2017 | Issued |
Array
(
[id] => 13814391
[patent_doc_number] => 10183956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-22
[patent_title] => Lanthanide toolbox for organelle specific molecular imaging
[patent_app_type] => utility
[patent_app_number] => 15/604660
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 76
[patent_figures_cnt] => 76
[patent_no_of_words] => 9278
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604660
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/604660 | Lanthanide toolbox for organelle specific molecular imaging | May 24, 2017 | Issued |
Array
(
[id] => 12092440
[patent_doc_number] => 20170349533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'STABLE SOLID FORMS OF ENCLOMIPHENE AND ENCLOMIPHENE CITRATE'
[patent_app_type] => utility
[patent_app_number] => 15/599592
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 23410
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599592
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599592 | STABLE SOLID FORMS OF ENCLOMIPHENE AND ENCLOMIPHENE CITRATE | May 18, 2017 | Abandoned |
Array
(
[id] => 15861247
[patent_doc_number] => 20200138027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => MICROBIOCIDAL OXADIAZOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/303115
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 578
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303115
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303115 | Microbiocidal oxadiazole derivatives | May 18, 2017 | Issued |
Array
(
[id] => 12029388
[patent_doc_number] => 20170319487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/599084
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23754
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599084
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599084 | Sustained release dosage forms for a JAK1 inhibitor | May 17, 2017 | Issued |
Array
(
[id] => 12979564
[patent_doc_number] => 20170342058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => FUMAGILLOL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 15/596512
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15596512
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/596512 | Fumagillol heterocyclic compounds and methods of making and using same | May 15, 2017 | Issued |
Array
(
[id] => 14341923
[patent_doc_number] => 20190152934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => METHOD OF PRODUCING POLYMERIZABLE COMPOUND, HALOGENATED COMPOUND, AND MIXTURE
[patent_app_type] => utility
[patent_app_number] => 16/098198
[patent_app_country] => US
[patent_app_date] => 2017-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098198
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098198 | METHOD OF PRODUCING POLYMERIZABLE COMPOUND, HALOGENATED COMPOUND, AND MIXTURE | May 10, 2017 | Abandoned |
Array
(
[id] => 16877913
[patent_doc_number] => 11028045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Process for reducing CPI in a dinitrile stream
[patent_app_type] => utility
[patent_app_number] => 16/095793
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6527
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095793
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095793 | Process for reducing CPI in a dinitrile stream | Apr 26, 2017 | Issued |
Array
(
[id] => 14534381
[patent_doc_number] => 20190202812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => Crystal Forms
[patent_app_type] => utility
[patent_app_number] => 16/166753
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166753
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/166753 | Crystal Forms | Apr 24, 2017 | Abandoned |
Array
(
[id] => 12469278
[patent_doc_number] => 09988341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Bacterial topoisomerase inhibitors and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/491679
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 14631
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15491679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/491679 | Bacterial topoisomerase inhibitors and use thereof | Apr 18, 2017 | Issued |
Array
(
[id] => 14276929
[patent_doc_number] => 20190135749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Production of Cyclic Imides Suitable for Oxidation Catalysis
[patent_app_type] => utility
[patent_app_number] => 16/096091
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096091
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096091 | Production of cyclic imides suitable for oxidation catalysis | Apr 17, 2017 | Issued |
Array
(
[id] => 15816579
[patent_doc_number] => 10633455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Method for treating and diagnosing disease using inhibitors of goodpasture antigen binding protein
[patent_app_type] => utility
[patent_app_number] => 15/485827
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 22960
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15485827
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/485827 | Method for treating and diagnosing disease using inhibitors of goodpasture antigen binding protein | Apr 11, 2017 | Issued |
Array
(
[id] => 14310591
[patent_doc_number] => 20190144999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => PROCESS FOR THE GENERATION OF THIN INORGANIC FILMS
[patent_app_type] => utility
[patent_app_number] => 16/092577
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092577 | PROCESS FOR THE GENERATION OF THIN INORGANIC FILMS | Apr 9, 2017 | Abandoned |
Array
(
[id] => 11821813
[patent_doc_number] => 20170210749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/481908
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90739
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15481908
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/481908 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE | Apr 6, 2017 | Abandoned |
Array
(
[id] => 11979291
[patent_doc_number] => 20170283445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'Small Molecule Inhibitors Selective For Polo-Like Kinase Proteins'
[patent_app_type] => utility
[patent_app_number] => 15/479373
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7686
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15479373
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/479373 | Small Molecule Inhibitors Selective For Polo-Like Kinase Proteins | Apr 4, 2017 | Abandoned |
Array
(
[id] => 17013579
[patent_doc_number] => 11083196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => Microbiocidal oxadiazole derivatives
[patent_app_type] => utility
[patent_app_number] => 16/087448
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29248
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087448
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/087448 | Microbiocidal oxadiazole derivatives | Mar 23, 2017 | Issued |
Array
(
[id] => 17822922
[patent_doc_number] => 11427861
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Methods for identifying and modulating co-occurant cellular phenotypes
[patent_app_type] => utility
[patent_app_number] => 16/085938
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 30
[patent_no_of_words] => 38697
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085938
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085938 | Methods for identifying and modulating co-occurant cellular phenotypes | Mar 16, 2017 | Issued |
Array
(
[id] => 13925975
[patent_doc_number] => 20190046503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/077359
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077359
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077359 | Compound for use in the treatment and/or prevention of parasitic mediated diseases | Mar 7, 2017 | Issued |
Array
(
[id] => 11704510
[patent_doc_number] => 20170173009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy'
[patent_app_type] => utility
[patent_app_number] => 15/449565
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43415
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449565
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449565 | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy | Mar 2, 2017 | Abandoned |
Array
(
[id] => 11704494
[patent_doc_number] => 20170172993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy'
[patent_app_type] => utility
[patent_app_number] => 15/449615
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40318
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449615
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449615 | Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy | Mar 2, 2017 | Abandoned |